YS Biopharma (YS) Short Interest Ratio & Short Volume → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free YS Stock Alerts $0.84 -0.07 (-7.73%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends YS Biopharma Short Interest DataCurrent Short Interest38,900 sharesPrevious Short Interest56,700 sharesChange Vs. Previous Month-31.39%Dollar Volume Sold Short$40,067.00Short Interest Ratio0.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares93,058,000 sharesFloat Size19,640,000 sharesShort Percent of Float0.20%Today's Trading Volume70,601 sharesAverage Trading Volume77,382 sharesToday's Volume Vs. Average91% Short Selling YS Biopharma ? Sign up to receive the latest short interest report for YS Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartYS Short Interest Over TimeYS Days to Cover Over TimeYS Percentage of Float Shorted Over Time Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. YS Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202438,900 shares $40,067.00 -31.4%0.2%0.2 $1.03 4/30/202456,700 shares $41,164.20 -40.9%0.3%0.3 $0.73 4/15/202495,900 shares $85,351.00 -1.0%0.5%0.4 $0.89 3/31/202496,900 shares $69,758.21 -17.0%0.5%0.5 $0.72 3/15/2024116,800 shares $84,446.40 -51.6%0.7%0.6 $0.72 2/29/2024241,400 shares $91,732.00 +25.5%1.4%1.3 $0.38 Get the Latest News and Ratings for YS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024192,300 shares $80,439.09 +124.7%1.1%1.3 $0.42 1/31/202485,600 shares $36,294.40 +1.7%0.4%0.6 $0.42 1/15/202484,200 shares $44,617.58 -28.5%0.4%0.8 $0.53 12/31/2023117,800 shares $60,195.80 -33.1%0.6%1.3 $0.51 12/15/2023176,200 shares $85,738.92 +7.8%0.9%1.9 $0.49 11/30/2023163,500 shares $91,560.00 -18.2%0.8%1.4 $0.56 11/15/2023199,900 shares $131,734.10 +52.0%1.0%0.2 $0.66 10/31/2023131,500 shares $57,860.00 -12.0%0.7%0.1 $0.44 10/15/2023149,400 shares $103,833.00 +124.7%0.8%0.2 $0.70 9/30/202366,500 shares $53,200.00 -32.4%0.3%0.1 $0.80 9/15/202398,300 shares $88,470.00 -86.1%0.5%0.1 $0.90 8/31/2023706,300 shares $840,497.00 +198.5%3.5%0.5 $1.19 8/15/2023236,600 shares $286,286.00 -23.7%1.2%0.4 $1.21 7/31/2023309,900 shares $440,058.00 +36.2%1.6%0.5 $1.42 7/15/2023227,600 shares $316,364.00 -18.1%1.1%0.3 $1.39 6/30/2023277,800 shares $383,364.00 -83.1%1.4%0.3 $1.38 6/15/20231,640,000 shares $2.26 million +86.1%8.3%1.3 $1.38 5/31/2023881,100 shares $1.33 million -3.3%4.4%1.1 $1.51 5/15/2023911,100 shares $1.13 million No Change4.6%1.2 $1.24 YS Short Interest - Frequently Asked Questions What is YS Biopharma's current short interest? Short interest is the volume of YS Biopharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 38,900 shares of YS short. 0.20% of YS Biopharma's shares are currently sold short. Learn More on YS Biopharma's current short interest. What is a good short interest percentage for YS Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.20% of YS Biopharma's floating shares are currently sold short. Is YS Biopharma's short interest increasing or decreasing? YS Biopharma saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 38,900 shares, a decrease of 31.4% from the previous total of 56,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is YS Biopharma's float size? YS Biopharma currently has issued a total of 93,058,000 shares. Some of YS Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. YS Biopharma currently has a public float of 19,640,000 shares. How does YS Biopharma's short interest compare to its competitors? 0.20% of YS Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to YS Biopharma: Verrica Pharmaceuticals Inc. (14.90%), Shattuck Labs, Inc. (3.85%), AC Immune SA (2.79%), Organogenesis Holdings Inc. (14.60%), Amarin Co. plc (3.91%), Precigen, Inc. (10.65%), Skye Bioscience, Inc. (0.13%), Nkarta, Inc. (16.27%), Nanobiotix S.A. (0.12%), UroGen Pharma Ltd. (19.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short YS Biopharma stock? Short selling YS is an investing strategy that aims to generate trading profit from YS Biopharma as its price is falling. YS shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against YS Biopharma? A short squeeze for YS Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of YS, which in turn drives the price of the stock up even further. How often is YS Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including YS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Verrica Pharmaceuticals Short Squeeze Shattuck Labs Short Squeeze AC Immune Short Squeeze Organogenesis Short Squeeze Amarin Short Squeeze Precigen Short Squeeze Skye Bioscience Short Squeeze Nkarta Short Squeeze Nanobiotix Short Squeeze UroGen Pharma Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:YS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.